68 Results for "

Janus Kinase

" in MedChemExpress (MCE) Product Catalog:
Products (68)

68 Results for "Janus Kinase" in MCE Product Catalog:

27
27 Publications Verification
Cat. No.: HY-19569
CAS No.: 1310726-60-3
Synonyms: ABT-494
Target:  

JAK

Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P80727
Synonyms: JAK2; Tyrosine-protein Kinase JAK2; Janus Kinase 2; JAK-2

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse

loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P700583
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: JAK1; JAK1A; JAK1B; Tyrosine-protein Kinase JAK1; Janus Kinase 1; JAK-1
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112708
CAS No.: 1883299-62-4
Purity:  99.97%
Synonyms: PF-06700841
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Brepocitinib (PF-06700841) is a potent dual Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. Brepocitinib also inhibits JAK2 and JAK3 with IC50s of 77 nM and 6.49 μM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112708A
CAS No.: 2140301-96-6
Purity:  99.98%
Synonyms: PF-06700841 P-Tosylate
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Brepocitinib (PF-06700841) P-Tosylate is a potent dual Janus kinase 1 (JAK1) and TYK2 inhibitor with IC50s of 17 nM and 23 nM, respectively. Brepocitinib P-Tosylate also inhibits JAK2 and JAK3 with IC50s of 77 nM and 6.49 μM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P7989
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: JAK2, Janus Kinase 2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19569R
CAS No.: 1310726-60-3
Synonyms: ABT-494 (Standard)
Target:  

Reference Standards JAK

Research Areas:  

Inflammation/Immunology

Upadacitinib (Standard) is the analytical standard of Upadacitinib. This product is intended for research and analytical applications. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136336
CAS No.: 1640971-51-2
Purity:  99.59%
Target:  

JAK

Research Areas:  

Others

Tofacitinib metabolite-1 is a metabolite of Tofacitinib and a JAK3 inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W727879
Synonyms: ABT-494-15N,d2
Upadacitinib- 15N,d2 (ABT-494- 15N,d2) is the deuterium-labeled Upadacitinib (HY-19569). Upadacitinib- 15N,d2 (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib- 15N,d2 (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib- 15N,d2 (ABT-494) can be used for several autoimmune disorders research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P701102
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: JAK 2; JAK-2; JAK2; JAK2_HUMAN; Janus Activating Kinase 2; Janus Kinase 2 (a protein tyrosine Kinase); Janus Kinase 2; JTK 10; JTK10; Kinase Jak2; OTTHUMP00000043260; THCYT3; Tyrosine protein Kinase JAK2; Tyrosine-protein Kinase JAK2
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80829A
Synonyms: JAK2; Tyrosine-protein Kinase JAK2; Janus Kinase 2; JAK-2

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80467
Synonyms: Tyrosine-protein Kinase JAK2, Janus Kinase 2, JAK-2, JAK2

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-145551
CAS No.: 2169273-59-8
Purity:  98.03%
Target:  

JAK Interleukin Related

Research Areas:  

Inflammation/Immunology

Atinvicitinib is an orally active and selective JAK1 inhibitor. Atinvicitinib blocks signaling of JAK1-dependent pruritogenic and pro-inflammatory cytokines, including those in the IL-31, IL-4, and IL-13 pathways. Atinvicitinib can be used for the researches of pruritus associated with allergic dermatitis and canine atopic dermatitis .
loading...
    loading...
Cat. No.: HY-P10373
CAS No.: 1259928-08-9
pJAK2(1001-1013) is a cell-penetrating peptide that corresponds to the activation loop of JAK2 tyrosine kinase and functions as a SOCS1/3antagonist. pJAK2 (1001-1013) blocks SOCS1-mediated negative regulation of immune function, and enhances the biological activity of cytokines such as IFNγ and IL6. pJAK2(1001-1013) inhibits the replication of a broad range of viruses and exerts dose-dependent protective efficacy against lethal viral infections. pJAK2(1001-1013) can be used for the study of immune regulation and infection .
loading...
    loading...
Cat. No.: HY-101976
CAS No.: 1443235-95-7
Purity:  99.90%
Target:  

JAK

Research Areas:  

Inflammation/Immunology

JAK3-IN-6 is a potent, selective irreversible Janus Associated Kinase 3 (JAK3) inhibitor, with an IC50 of 0.15 nM.
loading...
    loading...
Cat. No.: HY-W394903
CAS No.: 1257705-09-1
Target:  

Drug Metabolite JAK

Research Areas:  

Inflammation/Immunology

GS-829845 is a is a major, active metabolite of Filgotinib (HY-18300). GS-829845 is a JAK1 preferential inhibitor but is approximately 10-fold less potent than the parent and with a longer half-life .
loading...
    loading...
Cat. No.: HY-P1111
CAS No.: 222018-18-0
Target:  

Src Interleukin Related

Research Areas:  

Inflammation/Immunology

Lyn peptide inhibitor (YGYRLRRKWEEKIPNP-NH2) is a potent, cell-permeable Lyn kinase inhibitor that inhibits Lyn-coupled signaling pathways associated with the IL-5 receptor while preserving the integrity of other signals. Lyn peptide inhibitor blocks the activation of Lyn and inhibits the binding of Lyn tyrosine kinase to the βc subunit of the IL-3/GM-CSF/IL-5 receptor. Lyn peptide inhibitor can be used in the research of eosinophilic diseases such as asthma and allergy .
loading...
    loading...
Cat. No.: HY-N2521
CAS No.: 52328-97-9
Synonyms: FLLL31
Tetramethylcurcumin (FLLL31), derived from curcumin, specifically suppresses the phosphorylation of STAT3 by binding selectively to Janus kinase 2 and the STAT3 Src homology-2 domain. Tetramethylcurcumin exhibits anti-inflammatory and anti-cancer effects .
loading...
    loading...
Cat. No.: HY-145696
CAS No.: 2789678-92-6
Purity:  99.92%
Target:  

PROTACs JAK

Research Areas:  

Cancer

SJ10542 is a potent and selective JAK2/3 PROTAC degrader, with DC50 values of 14 nM and 11 nM against JAK2 and JAK3, respectively. SJ10542 exhibits anti-tumor activity and can be used for research on acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-148791
CAS No.: 2401057-12-1
Purity:  99.81%
Synonyms: PG-011
Target:  

JAK

Research Areas:  

Inflammation/Immunology Cancer

Pumecitinib is a Janus kinase (JAK) inhibitor. Pumecitinib shows anti-inflammatory activity .
loading...
    loading...